MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway
Chikungunya virus (CHIKV) epidemics around the world have created public health concern with the unavailability of effective drugs and vaccines. This emphasizes the need for molecular understanding of host-virus interactions for developing effective targeted antivirals. Microarray analysis was carri...
Guardado en:
Autores principales: | Prabhudutta Mamidi, Tapas Kumar Nayak, Abhishek Kumar, Sameer Kumar, Sanchari Chatterjee, Saikat De, Ankita Datey, Soumyajit Ghosh, Supriya Suman Keshry, Sharad Singh, Eshna Laha, Amrita Ray, Subhasis Chattopadhyay, Soma Chattopadhyay |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fbfa341d712c4abd9c6213d86efad4e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway.
por: Prabhudutta Mamidi, et al.
Publicado: (2021) -
VIPER regulates naive T cell activation and effector responses: Implication in TLR4 associated acute stage T cell responses
por: Subhransu Sekhar Sahoo, et al.
Publicado: (2018) - MK - Marketing más Ventas
-
Classification of Abrogation in the Qur’an
por: Israr Ahmad Khan
Publicado: (2006) -
A social engineering model for poverty alleviation
por: Amit K. Chattopadhyay, et al.
Publicado: (2020)